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Abstract 
Berberine is a compound that has various benefits but also has dangerous toxic effects. In Indonesia, 
the Regulation of the Head of the Food and Drug Supervisory Agency No. 10 of 2014 concerning the 
Prohibition of Producing and Circulating Traditional Medicines and Health Supplements Containing 
Coptis Sp, Berberis Sp, Mahonia Sp, Chelidonium Majus, Phellodendron Sp, Arcangelica Flava, 
Tinosporae Radix, and Catharanthus Roseus. Regulation No. 7 of 2018 (BPOM, 2018) also prohibits 
the presence of berberine in processed food. This research was conducted to determine the content 
of berberine compounds from the extract and stem fraction of Arcangelisia flava. The research was 
conducted by identifying the content of berberine by TLC method compared with Rf Berberine sulfate 
and determination of berberine content by HPLC method (High-Performance Liquid 
Chromatography) using column C-18 (ODS). Berberine content of methanol extract, n-hexane fraction, 
ethyl acetate fraction and Arcangelisia Flava methanol-water fraction were 0.0040, respectively; 
0.0010; 0.0041, 0.0044%. 
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Berberine is a plant alkaloid used in 
Ayurvedic and traditional Chinese medicine. 
Berberine can be found in Tinosporae Radix 
Chelidonium Majus, Phellodendron Sp, 
Hydrastis Canadensis [1], Coptis chinensis, 
Berberis aquifolium, Berberis vulgaris, Berberis 
aristata [2], Arcangelisia flava, Coscinium 
fenestratum, Acalypha Indica Linn [3], 
Scutellaria baicalensis [4] and several other 
plant species. 
Berberine [18,5,6-dihydro -9,10-
dimethoxybenzo(g) -1,3-benzodioxolo (5,6-a) 
quinolizinium], is a bright yellow crystalline 
form found in roots, stems, rhizomes, bark wood 
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and fruit. Currently, berberine is also 
commercially available in various salts such as 
berberine chloride and hemisulfate. The 















Berberine exhibits significant 
antimicrobial activity against various 
organisms, including bacteria, viruses, fungi, 
protozoa, and worms. Berberine has also been 
reported to have hepatoprotective activity [6], 
neuroprotective [2], [7], pulmonary fibrosis [8], 
and the most popular is anti-DM type 2 activity. 
In DM patients [9]. In China, berberine is an 
over-the-counter drug for the treatment of 
bacterial diarrhea. In 1988, a hypoglycemic 
effect of berberine was reported, and currently, 
berberine has been prescribed to treat type 1 
diabetes mellitus (type-1 diabetes). The 
mechanism of action of berberine in the 
treatment of type 1 DM is activating AMPK - 
Adenosine Monophosphate Protein Kinase, 
increasing insulin sensitivity, and stimulating 
pancreatic beta cell regeneration [10, p. 200]. In 
addition, information on the mechanism of 
action by repairing normal gastrointestinal flora 
[11] and regulation of PI3K/AKt and Nrf2 
signaling [12] are the reasons for the 
mechanism of action of berberine in improving 
hyperglycemic conditions. 
Berberine has also been reported to have 
antiplasmodial activity with the mechanism of 
action of inhibiting telomerase activity and in 
combination with pyrimethamine, showing 
better Plasmodium inhibition when compared 
to treatment using a combination of 
pyrimethamine and tetracycline or 
pyrimethamine and cotrimoxazole in patients 
with chloroquine-resistant malaria [13]. 
Berberine founds in the roots, rhizomes, and 
bark of plants Coptis sp., Berberis sp., Mahonia 
sp., Chelidonium Majus, Phellodendron sp., 
Arcangelisia Flava, in the roots of Tinosporae sp. 
[14] and on the stems of F. tinctoria and C. 
fenestratum [15]. On August 5, 2014, the 
Regulation of the National Food and Drug 
Agency No. 10 of 2014 concerning the 
Prohibition of Producing and Circulating 
Traditional Medicines and Health Supplements 
Containing Coptis Sp, Berberis Sp, Mahonia Sp, 
Chelidonium Majus, Phellodendron Sp, 
Arcangelica Flava, Tinosporae Radix, and 
Catharanthus Roseus. Regulation No. 7 of 2018 
[16] also prohibits the presence of berberine in 
processed food. These regulations are a follow-
up to the 2012 ASEAN TMHS Scientific 
Committee (ATSC) meeting on the negative list 
and restricted list of plants containing berberine 
and Catharanthus roseus for use in traditional 
medicines and health supplements in 
developing countries ASEAN members. 
This prohibition based on a reasonably 
narrow therapeutic index and toxic levels of 
berberine. The LD50 of berberine was 1,280 and 
520 mg/kg of extracts of Berberis vulgaris in 
rats and mice, respectively, for toxicity. 
Berberine sulfate isolated from Berberis 
aristata on intraperitoneal administration to 
rats had an LD50 value of 205 mg/kg. However, 
administration of 50 mg/kg Berberine sulfate 
caused diarrhea in 40% of rats which directly 
affected the gastrointestinal tract [17]. In cats, 
100 mg/kg (oral) berberine caused vomiting 
within 6-8 hours and, at the same dose for 8-10 
days, caused the death of all test animals. In cats, 
50/100 mg/kg for ten days oral administration 
of berberine sulfate causes hemorrhagic 
inflammatory problems in the small and large 
intestines. Some mild symptoms of low amounts 
of berberine and its toxicity have been seen in 
dogs. These symptoms are drooling, nausea, 
diarrhea, vomiting, muscle tremors, and 
sometimes paralysis also appear in dogs [17]. 
Sub-acute toxicity of berberine indicates gastric 
ulcer [18], Freund-induced chronic arthritis, 
enlarged liver and kidneys, increased body 
weight (up to 30%) [19], decreased binding of 
bilirubin protein in adult mice [20]. [21] have 
reported several immunotoxic effects of 
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berberine. It was reported that 10 mg/kg 
administration of berberine was responsible for 
reducing the number of leukocytes, neutrophils, 
lymphocytes (blood cell count), and spleen 
weight. Significant reductions in the 
generation/differentiation of B and T cells and 
splenic CD19+ B cells, CD4+ and CD8+ T cells 
were also associated with berberine. In total, 5 
mg/kg berberine was only responsible for 
influencing lymphocyte proliferation and 
delayed-type hypersensitivity responses, while 
10 mg/kg berberine was responsible for 
suppressing cellular and humoral immune 
functions [17] 
In East Borneo, the use of Arcangelisia 
Flava as an herb which is known as "bajakah 
kuning", has recently been widely used. With the 
many benefits of treatment and the potential for 
toxic effects, this study was conducted to 
analyze the levels of berberine in the extract and 
fraction of Arcangelisia flava. 
 
2 Materials and Methods  
2.1 Tools and Materials  
In this study, simplicia preparation and 
extraction were first carried out. Furthermore, 
identification of berberine content was carried 
out using the thin layer chromatography 
method by comparing the Rf of berberine 
chloride with the Rf produced from selected 
plant fractions. In addition to using TLC, 
identification was also carried out using High-
Performance Liquid Chromatography (HPLC) 
by analyzing the levels of berberine in the 
extract and its subsections. 
The materials used were simplicia 
Arcangelisia Flava, TLC plate, organic solvent 
with HPLC standard, Milli-Q-water, and column 
C-18. The tools used in the process of preparing 
simplicia and extraction as well as fractions are 
cutting tools, dryers, grinders, distillers, reflux 
devices and rotary evaporators, and separating 
funnels. For the identification process, the tools 
needed are chromatographic column, TLC 
chamber, and HPLC Waters e2695 and 2489 
UV/Vis instruments 
2.2 Identification of berberine by TLC 
Identification was carried out using the 
TLC and HPLC methods. In the TLC method, the 
stains that emerged from all fractions were 
compared with the stains of the standard 
berberine HCl using ethyl acetate, n-hexane, 
methanol, and formic acid in a ratio of 6:4:0.2:2. 
2.3 Identification of Berberine by HPLC 
2.3.1 Preparation of extract stock 
solutions, fractions, and berberine 
standards 
A total of 2 mg of extract, and the fraction 
dissolved in 5 ml of HPLC methanol with 
standard HPLC quality, then ultrasonicated and 
filtered with a 0.2 millipore filter. 
A total of 25 mg of standard berberine HCl 
was dissolved in 25 ml of methanol with 
standard HPLC quality, then ultrasonicated and 
filtered using a 0.2 millipore filter. Variations of 
standard concentrations of berberine were 
made with concentrations of 1, 5, 10, 20, 40, and 
80 ppm. 
2.3.2 Mobile Phase and Stationary 
Suitability Test 
The mobile phase adjustment method was 
carried out based on modifications from 
previous studies (Pasrija et al., 2010). The 
stationary phase used was C-18, while the 
mobile phase used was a mixture of 1.36 grams 
of potassium hydrogen phosphate dissolved in 
1000 ml of Milli-Q water. The pH adjusted to 2.5 
with the addition of phosphoric acid at a flow 
rate of 1 ml/min. with an injection volume of 10 
L . each 
2.3.3 Berberine Standard Calibration Curve 
Actions 
The stationary phase, mobile phase, and 
standard solution of berberine were prepared 
with various concentrations. Each standard 
solution of berberine HCl was injected into the 
HPLC column as much as 10 L at a flow rate of 1 
ml/min. Detection was carried out at a 
wavelength of 346 nm. The repetition is done 
five times. From the measurement data, a 
calibration curve is made with the equation  
y = ax + b. 
2.3.4 Determination of Berberine Levels 
The extract and the three fractions that 
have been made were injected into the HPLC 
column as much as 10 L with a flow rate of 1 
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ml/min. Detection was carried out at a 
wavelength of 346 nm. The test results are 
recorded. The test data were analyzed by using 
the standard curve equation, with the Y value 
being the AUC of the sample and X being the 
concentration of berberine in the test sample. 
The concentration of the injected material was 
determined. 
 
3 Results and Discussion 
After the sample preparation and 
extraction process was carried out, the extract 
was ready to be tested. The extract and the three 
fractions obtained were then identified for the 
content of berberine using Thin Layer 
Chromatography (TLC). TLC results can be seen 
in Figure 2. 
TLC results showed that the methanol 
extract, water-methanol fraction, and ethyl 
acetate fraction had stains parallel to the 
berberine stain with Rf 0.1. 
These results were confirmed using HPLC 
with the C-18 stationary phase and phosphate-
buffered mobile phase. Before the identification 
process is carried out, a validation process is 
carried out on the berberine standard. The 
results of the berberine calibration curve with 
an R-value of 0.99 can be seen in Figure 3. 
 
Figure 2. Results of identification of berberine in 
subfraction using TLC. Eluen:  
n-hexane:ethylacetate:methanol (3:7:2). The order of 
stains left to right: 1. F. tinctoria methanol extract, 2. 
Methanol-water fraction, 3. n-hexane fraction, 4. Ethyl 
acetate, and 5. Berberine  
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From the calibration curve, the equation 
y = 29947x - 10694 was obtained. Subsequently, 
the berberine content was determined in the 
water-methanol, n-hexane, and ethyl acetate 
fractions of A. Flava. The results of the assay 




Table 1. Berberine content in the extract and fraction 
Arcangelisia flava 
Sample Berberine (%) 
Methanol extract of A.flava 0,0040 
n-hexane fraction 0,0010 
Ethyl acetate fraction 0,0041 





From the results of identification and 
assay, it is known that berberine is contained in 
the methanol extract and the n-hexane fraction, 
ethyl acetate fraction, and the methanol-water 
fraction Arcangelisia Flava. Berberine content of 
methanol extract, n-hexane fraction, ethyl 
acetate fraction, and Arcangelisia Flava 
methanol-water fraction were 0.0040, 
respectively; 0.0010; 0.0041, 0.0044%. 
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